Clinical Activity of Pembrolizumab in Refractory
Therapeutic Advances in Medical Oncology（2024）
Key words
checkpoint inhibitor,immunotherapy,intimal sarcoma,pembrolizumab,tertiary lymphoid structure,vascular tissue neoplasm
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined